Clinical Trial

Timing of ctDNA Testing in Advanced Breast Cancer

Name: Timing of ctDNA Testing in Advanced Breast Cancer — clinical trial record (NCT07681323)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TIMING

Recruiting

View on ClinicalTrials.gov →

Summary

This multicenter, prospective observational cohort study aims to investigate the impact of circulating tumor DNA (ctDNA) level and key actionable gene mutation status on prognosis and treatment response in patients with advanced breast cancer.

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-09

Trial Details

NCT Number	NCT07681323
Lead Sponsor	Geneplus-Beijing Co. Ltd.
Conditions	Advanced Breast Cancer
Enrollment	400 participants
Start Date	2026-07-08
Primary Completion	2027-06-30 (estimated)
Study Completion	2029-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-22